AHIP Comment Letter to FTC on Competition in Prescription Drug Markets

On December 8, AHIP submitted comments to the Federal Trade Commission (FTC) for the official record of an FTC workshop held in early November on ways to promote greater competition in prescription drug markets—as a way to both reduce costs and improve access to drugs and treatments.